M. S. Saag

3.8k total citations · 1 hit paper
12 papers, 1.6k citations indexed

About

M. S. Saag is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, M. S. Saag has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in M. S. Saag's work include HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (3 papers). M. S. Saag is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (3 papers). M. S. Saag collaborates with scholars based in United States, United Kingdom and Austria. M. S. Saag's co-authors include P. G. Pappas, Robert A. Larsen, Jack D. Sobel, William E. Dismukes, William G. Powderly, John R. Perfect, Heidi M. Crane, Brandyn Lau, Joe Eron and M. J. Mugavero and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and Journal of Hepatology.

In The Last Decade

M. S. Saag

12 papers receiving 1.5k citations

Hit Papers

Practice Guidelines for the Management of Cryptococcal Di... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. S. Saag United States 9 1.2k 1.0k 225 217 146 12 1.6k
Antonio Ocampo Spain 22 1.0k 0.9× 704 0.7× 223 1.0× 587 2.7× 121 0.8× 86 1.8k
Barry S. Zingman United States 20 985 0.8× 652 0.6× 345 1.5× 438 2.0× 143 1.0× 57 1.6k
Adrian Palfreeman United Kingdom 14 788 0.7× 582 0.6× 300 1.3× 315 1.5× 62 0.4× 27 1.1k
B Gazzard United Kingdom 22 647 0.5× 477 0.5× 220 1.0× 319 1.5× 200 1.4× 49 1.4k
Suzanne Whitmore United States 9 690 0.6× 547 0.5× 178 0.8× 222 1.0× 68 0.5× 11 965
Catherine C. McGowan United States 25 1.1k 0.9× 733 0.7× 324 1.4× 391 1.8× 90 0.6× 84 1.7k
Daniela Garone South Africa 20 1.1k 0.9× 488 0.5× 280 1.2× 503 2.3× 109 0.7× 53 1.4k
Meaghan Kall United Kingdom 18 979 0.8× 662 0.7× 252 1.1× 197 0.9× 48 0.3× 48 1.3k
Hans Prozesky South Africa 26 1.8k 1.5× 934 0.9× 324 1.4× 719 3.3× 128 0.9× 62 2.3k
Trevor A. Crowell United States 22 945 0.8× 565 0.6× 203 0.9× 396 1.8× 56 0.4× 121 1.6k

Countries citing papers authored by M. S. Saag

Since Specialization
Citations

This map shows the geographic impact of M. S. Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Saag more than expected).

Fields of papers citing papers by M. S. Saag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Saag. The network helps show where M. S. Saag may publish in the future.

Co-authorship network of co-authors of M. S. Saag

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Saag. A scholar is included among the top collaborators of M. S. Saag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Saag. M. S. Saag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Young, Jim, Colette Smith, Ramón Teira, et al.. (2017). Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection. HIV Medicine. 19(2). 132–142. 8 indexed citations
2.
Cooper, C., Susanna Naggie, M. S. Saag, et al.. (2015). P1353 : A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection : The phase 3 ION-4 study. Journal of Hepatology. 62. S675–S676. 3 indexed citations
3.
Mugavero, M. J., Inmaculada Aban, Christa R. Nevin, et al.. (2011). Patient Reported Outcomes in Routine Care: Advancing Data Capture for HIV Cohort Research. Clinical Infectious Diseases. 54(1). 141–147. 67 indexed citations
4.
Mugavero, Michael J., Sonia Napravnik, S. R. Cole, et al.. (2011). Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy. Clinical Infectious Diseases. 53(9). 927–935. 106 indexed citations
5.
Cole, Stephen R., et al.. (2009). Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden. American Journal of Epidemiology. 171(2). 198–205. 85 indexed citations
6.
Zwahlen, Marcel, Margaret May, Robert S. Hogg, et al.. (2009). Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. UCL Discovery (University College London). 6 indexed citations
7.
Kitahata, Mari M., Benigno Rodríguez, Richard Haubrich, et al.. (2008). Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. International Journal of Epidemiology. 37(5). 948–955. 206 indexed citations
8.
Wingood, Gina M., Ralph J. DiClemente, Isis S. Mikhail, et al.. (2007). HIV Discrimination and the Health of Women Living with HIV. Women & Health. 46(2-3). 99–112. 99 indexed citations
9.
Bedimo, Roger, Ray Y. Chen, Neil A. Accortt, et al.. (2004). Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002. Clinical Infectious Diseases. 39(9). 1380–1384. 94 indexed citations
10.
Saag, M. S., Robert A. Larsen, P. G. Pappas, et al.. (2000). Practice Guidelines for the Management of Cryptococcal Disease. Clinical Infectious Diseases. 30(4). 710–718. 781 indexed citations breakdown →
11.
Stewart, Kirsten, Patricia G. Greene, Stephanie Call, et al.. (1998). Patterns of self-reported adherence to ART in a prospective clinical cohort. 38. 420–421. 6 indexed citations
12.
Wu, Albert W., Denise L. Jacobson, Dennis A. Revicki, et al.. (1997). The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS. Quality of Life Research. 6(1). 3–10. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026